Lunit
Developer of AI-based medical imaging and digital pathology software for cancer screening, biomarker discovery, and companion diagnostic research. Provides deep-learning analysis for mammography (2D and tomosynthesis), chest radiography, and whole-slide pathology (H&E and IHC); supports multimodal data integration and clinical validation; and partners with imaging vendors, cloud and analytics providers, CROs, and research organizations to deploy AI in clinical research and screening workflows.
Industries
Nr. of Employees
large (251-1000)
Patents
Apparatus and method for interlocking lesion locations between a guide image and a 3D tomosynthesis images composed of a plurality of 3D image slices
US-12694521-B2
View DetailsMethod and apparatus for providing information associated with immune phenotypes for pathology slide image
US-12688581-B2
View DetailsMethod and system for measuring size change of target lesion in x-ray image
US-12608809-B2
View Details
Apparatus and method for interlocking lesion locations between a guide image and a 3D tomosynthesis images composed of a plurality of 3D image slices
US-12694521-B2
View DetailsMethod and apparatus for providing information associated with immune phenotypes for pathology slide image
US-12688581-B2
View DetailsMethod and system for measuring size change of target lesion in x-ray image
US-12608809-B2
View DetailsProducts
AI mammography analysis (clinical screening)
Software that provides malignancy likelihood scoring and lesion localization in mammography to support radiologists and screening programs.
IHC quantification and pathology analysis (research-use platform)
Platform for quantitative IHC and whole-slide image analysis to support biomarker research, translational studies, and CDx development in oncology.
Lunit INSIGHT MMG and INSIGHT DBT
Improves accuracy and efficiency in 2D/3D mammography reading by detecting cancers earlier, reducing interval cancers and recalls, and boosting radiologist confidence without disrupting workflows.
Lunit INSIGHT Breast Suite
AI-powered software that improves accuracy and efficiency in 2D and 3D mammography reading.
Lunit INSIGHT® MMG
Detect breast cancer earlier with AI that improves 2D mammography accuracy and reduces callbacks.
Lunit INSIGHT® DBT
Speed up 3D tomosynthesis review with AI that highlights key slices and reduces reading fatigue.
AI mammography analysis (clinical screening)
Software that provides malignancy likelihood scoring and lesion localization in mammography to support radiologists and screening programs.
IHC quantification and pathology analysis (research-use platform)
Platform for quantitative IHC and whole-slide image analysis to support biomarker research, translational studies, and CDx development in oncology.
Lunit INSIGHT MMG and INSIGHT DBT
Improves accuracy and efficiency in 2D/3D mammography reading by detecting cancers earlier, reducing interval cancers and recalls, and boosting radiologist confidence without disrupting workflows.
Lunit INSIGHT Breast Suite
AI-powered software that improves accuracy and efficiency in 2D and 3D mammography reading.
Lunit INSIGHT® MMG
Detect breast cancer earlier with AI that improves 2D mammography accuracy and reduces callbacks.
Lunit INSIGHT® DBT
Speed up 3D tomosynthesis review with AI that highlights key slices and reduces reading fatigue.
Services
Image analysis service for mammograms and tomosynthesis to support screening programs and reduce reader workload.
Automated detection and scoring of common chest X‑ray findings to prioritize abnormal studies and support radiologist triage.
Risk scoring platform that automates validated clinical risk models, integrates with genetic testing labs, and connects to EHR systems to streamline risk workflows.
Platform for quantitative IHC and whole-slide image analysis to support biomarker discovery, translational studies, and companion diagnostic development.
Deep-learning analysis of H&E slides to quantify tumor-infiltrating lymphocytes, classify immune phenotypes, and support tumor microenvironment profiling for oncology research.
Technical documentation, DICOM conformance, imaging compatibility guides, and support services to integrate AI tools into existing clinical and laboratory infrastructure.
Image analysis service for mammograms and tomosynthesis to support screening programs and reduce reader workload.
Automated detection and scoring of common chest X‑ray findings to prioritize abnormal studies and support radiologist triage.
Risk scoring platform that automates validated clinical risk models, integrates with genetic testing labs, and connects to EHR systems to streamline risk workflows.
Platform for quantitative IHC and whole-slide image analysis to support biomarker discovery, translational studies, and companion diagnostic development.
Deep-learning analysis of H&E slides to quantify tumor-infiltrating lymphocytes, classify immune phenotypes, and support tumor microenvironment profiling for oncology research.
Technical documentation, DICOM conformance, imaging compatibility guides, and support services to integrate AI tools into existing clinical and laboratory infrastructure.
Expertise Areas
- Clinical validation and regulatory strategy for medical AI
- AI-driven radiology for breast and chest imaging
- Digital pathology and whole-slide image analysis
- IHC quantification and translational assay support
Key Technologies
- Deep learning for medical imaging
- Convolutional neural networks for radiology
- Whole-slide image analysis
- IHC quantification algorithms
News & Updates
Strategic partnership with a global CRO to offer AI pathology analysis as part of CRO laboratory services for clinical trials, integrating whole-slide H&E and IHC analysis into trial workflows.
Collaboration with a spatial biology provider to combine spatial molecular platforms with AI-based H&E analysis to advance oncology biomarker discovery.
Acquisition that expanded mammography quality-assurance and breast-density assessment capabilities and added presence in US clinical sites.
Agreement to combine AI algorithms with tissue-based diagnostic expertise from a diagnostics vendor to develop companion diagnostic tools for precision medicine.
Partnership with an imaging vendor to make chest abnormality detection AI available within the vendor's diagnostic X‑ray platform for broader clinical deployment.
Supply contract to integrate chest radiograph analysis and triage software into an imaging vendor's premium X‑ray devices for deployment in markets including the US, Canada and Europe; initial deployments targeted for ICU and ER settings.
Strategic partnership with a global CRO to offer AI pathology analysis as part of CRO laboratory services for clinical trials, integrating whole-slide H&E and IHC analysis into trial workflows.
Collaboration with a spatial biology provider to combine spatial molecular platforms with AI-based H&E analysis to advance oncology biomarker discovery.
Acquisition that expanded mammography quality-assurance and breast-density assessment capabilities and added presence in US clinical sites.
Agreement to combine AI algorithms with tissue-based diagnostic expertise from a diagnostics vendor to develop companion diagnostic tools for precision medicine.
Partnership with an imaging vendor to make chest abnormality detection AI available within the vendor's diagnostic X‑ray platform for broader clinical deployment.
Supply contract to integrate chest radiograph analysis and triage software into an imaging vendor's premium X‑ray devices for deployment in markets including the US, Canada and Europe; initial deployments targeted for ICU and ER settings.